News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
898,207 Results
Type
Article (89679)
Company Profile (639)
Press Release (807865)
Multimedia
Podcasts (283)
Webinars (44)
Section
Business (267515)
Career Advice (4176)
Deals (40164)
Drug Delivery (246)
Drug Development (92153)
Employer Resources (212)
FDA (18738)
Job Trends (17563)
News (399636)
Policy (40038)
Tag
2025 Best Places to Work (25)
2026 Best Places to Work (39)
2027 BioCapital Standard (5)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (13)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Standard (7)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 NextGen (10)
2027 Pharm Country Digital (4)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (3112)
Academic (2)
Accelerated approval (77)
ADA (54)
Adcomms (44)
Allergies (237)
Alliances (57000)
ALS (293)
Alzheimer's disease (2152)
Antibody-drug conjugate (ADC) (779)
Approvals (19336)
Artificial intelligence (1147)
ASCO (350)
Autoimmune disease (537)
Automation (84)
Bankruptcy (414)
Belgium (45)
Best Places to Work (12636)
BIO (84)
Biologics (121)
BIOSECURE Act (23)
Biosimilars (308)
BioSpace Insights (271)
Biotechnology (340)
Bispecific (60)
Bladder cancer (253)
Brain cancer (104)
Breast cancer (981)
Cancer (8075)
Cardiovascular disease (684)
Career advice (3638)
Career pathing (65)
CAR-T (465)
CDC (82)
CDMO (237)
Celiac Disease (7)
Cell-line development (2)
Cell therapy (1280)
Cervical cancer (69)
Clinical research (81254)
Collaboration (2896)
Commercialization (76)
Company closure (10)
Compensation (1937)
Complete response letters (128)
COVID-19 (3089)
CRISPR (155)
CRO (8)
C-suite (1714)
Cystic fibrosis (183)
Data (11188)
Decentralized trials (4)
Denatured (112)
Depression (230)
Dermatology (208)
Diabetes (855)
Diagnostics (7952)
Digital health (86)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (566)
Drug pricing (255)
Drug shortages (41)
Duchenne muscular dystrophy (388)
Earnings (104815)
Editorial (85)
Employer branding (27)
Employer resources (184)
ESMO (441)
Events (141999)
Executive appointments (1385)
Eye disease (28)
FDA (23875)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (43)
Funding (2385)
Gene editing (323)
Generative AI (116)
Gene therapy (991)
GLP-1 (1417)
Government (5635)
Grass and pollen (8)
Guidances (446)
Healthcare (21523)
Hematology (236)
HIV (128)
Huntington's disease (93)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (155)
Immunology and inflammation (432)
Immuno-oncology (166)
Indications (299)
Infectious disease (3551)
Inflammatory bowel disease (285)
Inflation Reduction Act (17)
Influenza (168)
Intellectual property (391)
Interviews (830)
IPO (18072)
IRA (61)
Job creations (5211)
Job search strategy (2882)
JPM (73)
Kidney cancer (32)
Kidney disease (182)
Labor market (152)
Layoffs (733)
Leadership (70)
Legal (10180)
Licensing (132)
Liver cancer (121)
Longevity (58)
Lung cancer (1112)
Lung diease (27)
Lymphoma (568)
Machine learning (78)
Management (72)
Manufacturing (1663)
Marketing (41)
MASH (260)
Medical affairs (5)
Medical device (15487)
Medtech (15824)
Mergers & acquisitions (23653)
Metabolic disorders (2177)
Middle East (2)
mRNA (345)
Multiple sclerosis (263)
Multispecific (6)
NASH (24)
Netherlands (41)
Neurodegenerative disease (637)
Neuropsychiatric disorders (155)
Neuroscience (4373)
Neurotech (4)
NextGen: Class of 2026 (7718)
Non-profit (5176)
Now hiring (101)
Obesity (1028)
Opinion (410)
Ovarian cancer (301)
Pain (353)
Pancreatic cancer (459)
Parkinson's disease (496)
Partnered (53)
Patents (816)
Patient advocacy (8)
Patient recruitment (988)
Patient selection (117)
Peanut (81)
People (69168)
Peptides (45)
Pharmaceutical (83)
Pharmacy benefit managers (43)
Phase 1 (25057)
Phase 2 (35294)
Phase 3 (26606)
Pipeline (14702)
Policy (435)
Postmarket research (3561)
Preclinical (11211)
Press Release (74)
Prostate cancer (414)
Psychedelics (105)
Radioligand (3)
Radiopharmaceuticals (449)
Rare diseases (1617)
Real estate (7479)
Recruiting (84)
Regenerative medicine (38)
Regulatory (31915)
Reports (104)
Research institute (2823)
Resumes & cover letters (657)
Rett syndrome (60)
RNA editing (39)
RSV (107)
Saudi Arabia (1)
Schizophrenia (231)
Series A (410)
Series B (285)
Service/supplier (17)
Sickle cell disease (153)
Special edition (38)
Spinal muscular atrophy (201)
Sponsored (61)
Startups (4405)
State (2)
Stem cells (8)
Stomach cancer (24)
Substance use disorders (23)
Supply chain (173)
Switzerland (25)
Tariffs (108)
Tax incentives (2)
The Weekly (168)
Vaccines (1449)
Venture capital (186)
Weight loss (684)
Wet AMD (7)
Women's health (190)
Women in leadership (2)
Worklife (28)
Date
Today (246)
Last 7 days (994)
Last 30 days (4078)
Last 365 days (34048)
2026 (30836)
2025 (33214)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51334)
2018 (39119)
2017 (37186)
2016 (38329)
2015 (44431)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1310)
Alabama (118)
Alaska (7)
Arizona (493)
Arkansas (17)
Asia (53212)
Australia (9371)
California (17384)
Canada (4783)
China (2070)
Colorado (772)
Connecticut (776)
Delaware (549)
Europe (122876)
Florida (2635)
Georgia (567)
Hawaii (5)
Idaho (70)
Illinois (1503)
India (156)
Indiana (786)
Iowa (37)
Japan (783)
Kansas (160)
Kentucky (69)
Louisiana (73)
Maine (99)
Maryland (2049)
Massachusetts (12579)
Michigan (477)
Minnesota (954)
Mississippi (8)
Missouri (190)
Montana (38)
Nebraska (31)
Nevada (206)
New Hampshire (94)
New Jersey (4602)
New Mexico (38)
New York (4529)
North Carolina (2250)
North Dakota (14)
Northern California (8880)
Ohio (543)
Oklahoma (32)
Oregon (55)
Pennsylvania (3327)
Puerto Rico (38)
Rhode Island (66)
South America (1674)
South Carolina (105)
South Dakota (2)
Southern California (6929)
Tennessee (289)
Texas (2895)
United States (61617)
Utah (528)
Vermont (2)
Virginia (436)
Washington D.C. (89)
Washington State (1388)
West Virginia (4)
Wisconsin (200)
Wyoming (6)
There are 898,207 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vittoria Biotherapeutics to Present Phase 1 Results for Senza5 CART5 in T-Cell Lymphoma in an Oral Session and LampTAC Degrader Platform Data in a Poster Session at ASH 2026
November 17, 2026
·
4 min read
Press Releases
CytoDyn Appoints Lauren Wilcoxen, Ph.D., as Chief Operating Officer and Head of Regulatory Affairs
November 17, 2026
·
4 min read
Press Releases
Veru Presents New Results at ObesityWeek 2026: GLP-1 Weight Loss in Older Adults Associated with Physical Function Decline; Adding Enobosarm Preserved Significant Lean Mass and Physical Function
November 17, 2026
·
21 min read
Press Releases
MAIA Biotechnology Reports Consistent Strong Efficacy in Expanded Phase 2 THIO-101 Study in Non-Small Cell Lung Cancer
November 17, 2026
·
7 min read
Cancer
Sellas’ cancer vaccine slashes death risk by 41% in late-stage AML study
Sellas Life Sciences’ investigational cancer vaccine prolonged median overall survival by over nine months compared to standard of care in a Phase 3 trial for difficult-to-treat acute myeloid leukemia.
November 17, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
NeOnc Reports Additional Partial Response in Phase 2a Study of Intranasal NEO100
November 17, 2026
·
4 min read
Press Releases
Valion Bio Reports Completion of 200-Liter Entolimod Production Run; Material Supplying Ongoing AFRRI Study
November 17, 2026
·
6 min read
Press Releases
Senti Bio Announces Reverse Stock Split
November 17, 2026
·
6 min read
Press Releases
Nasus Pharma Presents Data at ACAAI 2026 Demonstrating NS002 Reached the Therapeutic Epinephrine Threshold Faster Than an Autoinjector After Repeat Dosing and Under Severe Nasal Congestion
November 17, 2026
·
4 min read
Press Releases
Faron Pharmaceuticals LTD: Holding(s) in Company - November 17, 2026
November 17, 2026
·
3 min read
1 of 89,821
Next